Your browser doesn't support javascript.
loading
PARP Inhibition, a New Therapeutic Avenue in Patients with Prostate Cancer.
Flippot, Ronan; Patrikidou, Anna; Aldea, Mihaela; Colomba, Emeline; Lavaud, Pernelle; Albigès, Laurence; Naoun, Natacha; Blanchard, Pierre; Terlizzi, Mario; Garcia, Camilo; Bernard-Tessier, Alice; Fuerea, Alina; Di Palma, Mario; Escudier, Bernard; Loriot, Yohann; Baciarello, Giulia; Fizazi, Karim.
Afiliación
  • Flippot R; Department of Cancer Medicine, Paris Saclay University, Gustave Roussy, 114 rue Edouard Vaillant, 94 800, Villejuif, France.
  • Patrikidou A; Department of Cancer Medicine, Paris Saclay University, Gustave Roussy, 114 rue Edouard Vaillant, 94 800, Villejuif, France.
  • Aldea M; Department of Cancer Medicine, Paris Saclay University, Gustave Roussy, 114 rue Edouard Vaillant, 94 800, Villejuif, France.
  • Colomba E; Department of Cancer Medicine, Paris Saclay University, Gustave Roussy, 114 rue Edouard Vaillant, 94 800, Villejuif, France.
  • Lavaud P; Department of Cancer Medicine, Paris Saclay University, Gustave Roussy, 114 rue Edouard Vaillant, 94 800, Villejuif, France.
  • Albigès L; Department of Cancer Medicine, Paris Saclay University, Gustave Roussy, 114 rue Edouard Vaillant, 94 800, Villejuif, France.
  • Naoun N; Department of Cancer Medicine, Paris Saclay University, Gustave Roussy, 114 rue Edouard Vaillant, 94 800, Villejuif, France.
  • Blanchard P; Department of Radiation Oncology, Paris Saclay University, Gustave Roussy, Villejuif, France.
  • Terlizzi M; Department of Radiation Oncology, Paris Saclay University, Gustave Roussy, Villejuif, France.
  • Garcia C; Department of Nuclear Medicine, Paris Saclay University, Gustave Roussy, Villejuif, France.
  • Bernard-Tessier A; Department of Cancer Medicine, Paris Saclay University, Gustave Roussy, 114 rue Edouard Vaillant, 94 800, Villejuif, France.
  • Fuerea A; Department of Cancer Medicine, Paris Saclay University, Gustave Roussy, 114 rue Edouard Vaillant, 94 800, Villejuif, France.
  • Di Palma M; Department of Cancer Medicine, Paris Saclay University, Gustave Roussy, 114 rue Edouard Vaillant, 94 800, Villejuif, France.
  • Escudier B; Department of Cancer Medicine, Paris Saclay University, Gustave Roussy, 114 rue Edouard Vaillant, 94 800, Villejuif, France.
  • Loriot Y; Department of Cancer Medicine, Paris Saclay University, Gustave Roussy, 114 rue Edouard Vaillant, 94 800, Villejuif, France.
  • Baciarello G; Istituto Nazionale dei Tumori, Milan, Italy.
  • Fizazi K; Department of Cancer Medicine, Paris Saclay University, Gustave Roussy, 114 rue Edouard Vaillant, 94 800, Villejuif, France. karim.fizazi@gustaveroussy.fr.
Drugs ; 82(7): 719-733, 2022 May.
Article en En | MEDLINE | ID: mdl-35511402
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Inhibidores de Poli(ADP-Ribosa) Polimerasas Límite: Humans / Male Idioma: En Revista: Drugs Año: 2022 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Nueva Zelanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Inhibidores de Poli(ADP-Ribosa) Polimerasas Límite: Humans / Male Idioma: En Revista: Drugs Año: 2022 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Nueva Zelanda